Although the high level of MSI2 has been linked to high-grade NSCLC and metastatic staging in patients [16, 17], which was validated in the present study (Fig. 1A–I), the expression of MSI2 and its functional role in TME stromal cells during tumor progression and metastasis have never been studied. The gene discussed is MSI2; the disease is non-small cell lung carcinoma.